Fluoxetine (Prozac) for PMDD: does it work?

Yes, for most women who try it. Fluoxetine (sold as Prozac, and sometimes as Sarafem) is a selective serotonin reuptake inhibitor (SSRI), and it's one of the best-studied medications for premenstrual dysphoric disorder (PMDD).

In the largest trial on the drug, 313 women with confirmed PMDD entered a randomized, six-cycle trial of 20 mg or 60 mg of fluoxetine or a placebo, after an initial two-cycle placebo washout involving 405 women. Both doses reduced tension, irritability, and dysphoria more than placebo (p < 0.001) (New England Journal of Medicine, 1995). A separate crossover trial of 17 women found that 65% no longer met the criteria for PMDD while taking fluoxetine, but stayed symptomatic on placebo (Neuropsychopharmacology, 1997).

Fluoxetine also beat a non-serotonergic antidepressant, bupropion, in a small trial of 34 women, though the trial was too small to explain why (Journal of Clinical Psychopharmacology, 1997). For how PMDD differs from ordinary premenstrual symptoms, see PMDD, explained.

Beyond that first large trial, fluoxetine has been tested against other treatments for PMDD, not only against placebo.

• A six-month trial comparing cognitive behavioral therapy (CBT), fluoxetine (20 mg a day), and the two combined found all three groups improved, with fluoxetine working faster but CBT holding its gains better at one-year follow-up (Journal of Psychosomatic Obstetrics & Gynaecology, 2002).
• A small trial compared fluoxetine with Vitex agnus-castus (chasteberry extract) and found similar overall response rates, though fluoxetine worked better for mood symptoms and Vitex for physical ones (Human Psychopharmacology, 2003).
• An early placebo-controlled trial found 9 of 10 women responded to fluoxetine 20 mg a day, against 2 of 10 on placebo (Journal of Clinical Psychiatry, 1991).

Most of this research is specific to PMDD, confirmed over at least two cycles of daily ratings rather than a single bad week. For other SSRIs with trial support in PMDD, see SSRIs for PMDD.

Trials have tested two main approaches, and a doctor decides which one fits your history and symptom pattern.

• Daily, all month: 20 mg a day, taken continuously, is the regimen with the most trial support and was used in the largest study (New England Journal of Medicine, 1995).
• Luteal phase only: fluoxetine taken just in the two weeks before your period, starting around day 14 of the cycle through the first day or two of bleeding. One trial found luteal-only 20 mg eased symptoms more than placebo, while 10 mg luteal-only wasn't better than placebo (Obstetrics and Gynecology, 2002); this trial didn't test luteal-only against daily dosing directly.
• Premenstrual, intermittent: a separate trial found 14-day premenstrual dosing was about as effective as continuous daily dosing and reported few side effects, though the two groups differed in psychiatric history going in, so it isn't a clean head-to-head comparison (Psychopharmacology Bulletin, 1997).

A doctor will weigh how regular your cycle is before suggesting luteal-only dosing, since it depends on predicting ovulation reasonably well. For how doses are typically adjusted, see fluoxetine dosage.

Many women notice some change within the first treated cycle. In the luteal-phase trial, daily symptom scores improved by the first cycle on 20 mg, though the effect only stayed ahead of placebo throughout the full study at that dose (Obstetrics and Gynecology, 2002).

The six-cycle trial followed women for six full months to confirm the benefit held up over time rather than fading, and it did (New England Journal of Medicine, 1995). In plain terms, some women feel relief by the first or second cycle, and the clearer picture usually shows up after two to three cycles of daily tracking. For a broader look at SSRI timelines, see how long does fluoxetine take to work.

Fluoxetine's side effects are dose-related. In the largest trial, women on 60 mg reported significantly more side effects than those on 20 mg or placebo (p < 0.001), which is part of why 20 mg became the standard starting point (New England Journal of Medicine, 1995).

Across trials, the side effects reported with fluoxetine for PMDD are the same ones seen with SSRIs generally:

• Nausea, especially in the first days
• Headache
• Trouble sleeping, or feeling drowsy
• Dry mouth
• Reduced sex drive or delayed orgasm

Most of these ease after the first few weeks. Taking fluoxetine only in the luteal phase, rather than all month, can also mean fewer days of side effects overall. For a fuller list and what to do about each one, see fluoxetine side effects.

A doctor reviews your full history before prescribing fluoxetine, including any history of bipolar disorder (SSRIs can occasionally trigger a manic episode), other medications you take (especially MAOIs, which can't be combined with fluoxetine), and whether you're pregnant, trying to conceive, or breastfeeding.

None of the trials above screened for every one of these factors the same way, so this is general SSRI caution rather than a PMDD-specific finding. Tell whoever prescribes it that you suspect PMDD specifically, since it's often mistaken for plain depression or anxiety. That's a conversation for the person treating you, not something to decide from a page like this one.

Medication isn't the only option, and it doesn't have to work alone. The CBT-versus-fluoxetine trial found cognitive behavioral therapy worked about as well as fluoxetine by six months, and held its gains better a year later, so some women end up doing both (Journal of Psychosomatic Obstetrics & Gynaecology, 2002).

Daily symptom tracking across two cycles is also how PMDD gets diagnosed in the first place, and it's what every trial here used to judge whether fluoxetine was actually helping. Niyora is a PMS and PMDD support app, and its Moon feature can give you somewhere to put a bad moment while you wait for any treatment to take effect: write down what happened, see it from another angle, and draft a reply you can hold onto instead of sending it straight away.